— Know what they know.
Not Investment Advice
Also trades as: 4547.T (JPX) · $vol 2M

KSPHF OTC

Kissei Pharmaceutical Co., Ltd.
1W: -2.4% 1M: -4.9% 3M: -4.9% YTD: -9.2% 1Y: -19.1% 3Y: +35.8% 5Y: +25.6%
$24.50
-1.27 (-4.93%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 53 · $1.0B mcap · 24M float · 0.0004% daily turnover · Short 100% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 01, 2026
DCF
1
ROE
3
ROA
5
D/E
2
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. KSPHF receives an overall rating of B+. Strongest factors: ROA (5/5), P/B (4/5). Areas of concern: DCF (1/5), D/E (2/5).
Rating Change History
DateFromTo
2026-09-29 None ADDED
2026-09-27 EXISTED None
2026-09-23 None ADDED
2026-09-23 EXISTED None
2026-09-19 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-13 EXISTED None
2026-09-09 None ADDED
2026-09-05 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade C
Profitability
34
Balance Sheet
96
Earnings Quality
42
Growth
58
Value
—
Momentum
56
Safety
—
Cash Flow
16

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✓ ✗ ✓ ✗ ✓ ✗ ✓
Beneish M-Score
-2.13
Unlikely Manipulator
Ohlson O-Score
-11.90
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 79.6/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: 0.33x
Accruals: 3.6%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. KSPHF scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. KSPHF's score of -2.13 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. KSPHF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. KSPHF receives an estimated rating of A+ (score: 79.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). KSPHF's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
10.97x
PEG
0.67x
P/S
1.56x
P/B
0.67x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$6485.48
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 11.0x earnings, KSPHF trades at a reasonable valuation. Graham's intrinsic value formula yields $6485.48 per share, suggesting a potential 26371% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.816
NI / EBT
×
Interest Burden
1.571
EBT / EBIT
×
EBIT Margin
0.110
EBIT / Rev
×
Asset Turnover
0.376
Rev / Assets
×
Equity Multiplier
1.182
Assets / Equity
=
ROE
6.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. KSPHF's ROE of 6.3% is driven by Asset Turnover (0.376), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$12871.03
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with KSPHF's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. KSPHF actually compounded EPS at 481.9% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. KSPHF trades at a premium to its adjusted intrinsic value of $12871.03, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 11.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$24.50
Median 1Y
$24.32
5th Pctile
$15.57
95th Pctile
$38.11
Ann. Volatility
27.1%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 3.3% 0.9% -1.0% 0.1% 5.3% 5.2% 6.2% 0.0% 6.2% 6.8% 2.8% 2.7% 8.7% 9.7% 5.7% 5.6% 5.8% 6.7% 6.6% 6.3% 6.29%
ROA 2.7% 0.7% -0.8% 5.1% 4.4% 4.3% 5.2% 4.3% 5.4% 5.9% 1.6% 4.2% 7.4% 8.2% 9.3% 4.7% 4.9% 11.1% 5.6% 5.3% 5.32%
ROIC -5.6% -21.0% -95.7% -0.0% -0.9% -1.4% -0.3% -0.0% 0.2% 0.8% 1.0% 0.9% 1.8% 1.7% 1.9% 2.7% 2.8% -1.2% -1.1% -1.4% -1.41%
ROCE 4.4% 4.4% 4.0% -98.5% 8.9% 9.1% 10.4% -1.0% 11.0% 11.7% -1.0% 4.5% 7.7% 6.3% 6.1% 6.9% 2.5% -30.4% 4.9% 4.2% 4.23%
Gross Margin 47.3% 48.2% 48.9% 46.6% 50.0% 48.5% 49.0% 44.1% 49.6% 49.4% 0.3% 49.5% 51.4% 49.4% 50.5% 48.3% 49.9% 49.1% 45.9% 43.7% 43.70%
Operating Margin 1.8% -0.1% -3.2% -7.3% 0.8% -4.6% 6.0% -10.2% 8.5% 2.2% 10.3% -0.8% 10.2% -1.8% 10.6% 6.8% 9.5% -37.8% 11.8% 3.1% 3.05%
Net Margin 21.9% 12.8% 6.5% 39.9% 10.0% 10.2% 17.8% 24.4% 16.9% 13.7% 12.7% 15.9% 19.4% 5.4% 15.5% 13.8% 20.4% 13.8% 12.1% 11.2% 11.16%
EBITDA Margin 6.9% 6.0% 1.5% -1.4% 6.8% 1.5% 11.5% -3.4% 13.7% 11.9% 15.2% 5.2% 62.7% 3.6% 15.2% 11.9% 14.7% 20.5% 20.1% 7.9% 7.87%
FCF Margin -0.0% -0.2% -0.7% -16.8% -13.9% -10.7% -6.8% -10.5% -13.6% -16.9% -0.5% -2.5% -3.0% -3.3% -4.2% -2.6% -1.1% 0.3% 1.6% -0.5% -0.49%
OCF Margin 0.1% 0.0% -0.1% 64.1% 1.4% 2.2% 3.0% -1.0% -5.0% -9.0% -31.4% -14.0% -7.0% -3.6% -2.0% 0.4% 2.7% 4.9% 6.8% 4.6% 4.61%
ROE 3Y Avg snapshot only 4.74%
ROE 5Y Avg snapshot only 2.86%
ROA 3Y Avg snapshot only 4.01%
ROIC 3Y Avg snapshot only 2.56%
ROIC Economic snapshot only -1.09%
Cash ROA snapshot only 1.63%
Cash ROIC snapshot only 2.54%
CROIC snapshot only -0.27%
NOPAT Margin snapshot only -2.57%
Pretax Margin snapshot only 17.33%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 50.15%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 10.967
P/S Ratio — — — — — — — — — — — — — — — — — — — — 1.555
P/B Ratio — — — — — — — — — — — — — — — — — — — — 0.670
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.665
Graham Number snapshot only $6485.48
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 5.26 4.65 5.11 5.30 6.27 6.03 5.27 6.73 6.27 6.32 5.93 5.92 6.56 5.50 5.38 6.45 5.86 0.02 4.50 5.30 5.301
Quick Ratio 4.15 3.74 4.02 4.29 5.03 4.82 4.18 5.20 4.81 4.85 5.92 4.43 4.93 4.15 4.05 4.95 4.46 -0.75 3.42 4.12 4.124
Debt/Equity 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.005
Net Debt/Equity -0.20 -0.23 -0.20 -0.26 -0.23 -0.25 -0.23 -0.25 -0.23 -0.23 -0.21 -0.20 -0.20 -0.22 -0.21 -0.23 -0.23 -0.00 -0.21 -0.23 -0.231
Debt/Assets 0.01 0.01 0.01 0.84 0.01 0.01 0.01 0.89 0.01 0.01 0.86 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.005
Debt/EBITDA 0.01 0.01 0.03 1.80 0.02 0.28 -0.11 66.79 0.44 0.01 0.30 0.24 0.07 0.07 0.07 0.06 0.13 0.00 0.11 0.08 0.081
Net Debt/EBITDA -0.20 -0.20 -0.44 -56.47 -0.38 -6.06 2.28 -2156.59 -9.73 -0.21 -9.10 -8.08 -2.37 -2.69 -2.34 -2.34 -4.64 -0.03 -2.77 -3.44 -3.445
Interest Coverage 532.06 748.91 1242.39 82502.32 74939.23 79150.27 105848.27 93127.59 115266.45 122568.96 3856.73 2699.96 2318.68 1886.62 3486.75 3869.06 70133.53 1367.93 815.68 486.41 486.412
Equity Multiplier 1.21 1.22 1.20 0.01 1.17 1.17 1.18 0.01 1.15 1.16 0.01 1.19 1.17 1.19 1.18 1.17 1.18 0.01 1.20 1.20 1.195
Cash Ratio snapshot only 2.509
Debt Service Coverage snapshot only 699.733
Cash to Debt snapshot only 43.539
FCF to Debt snapshot only -0.385
Defensive Interval snapshot only 643.2 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 0.40 0.28 0.13 0.26 0.26 0.27 0.26 0.27 0.31 0.33 12.59 0.30 0.46 0.62 0.67 0.35 0.36 0.70 0.38 0.38 0.376
Inventory Turnover 3.50 2.37 1.17 0.03 1.77 1.73 1.55 0.01 1.74 1.76 125.84 1.22 3.06 3.84 3.11 1.73 1.76 1.77 1.86 2.05 2.047
Receivables Turnover 2.45 1.69 0.64 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.75 1.56 2.24 2.98 2.67 3.11 3.20 6.66 2.84 3.27 3.269
Payables Turnover 5.35 3.93 1.52 0.05 0.07 0.05 0.05 0.06 0.06 0.05 4.04 6.28 15.73 10.22 8.34 9.32 16.27 17.57 7.00 9.17 9.175
DSO 149 216 569 14393 14813 15619 19429 16174 16689 17546 486 234 163 123 136 117 114 55 129 112 111.6 days
DIO 104 154 311 11740 206 211 236 29484 210 207 3 300 119 95 117 211 207 206 196 178 178.3 days
DPO 68 93 240 7357 5372 6928 7966 6154 5952 6669 90 58 23 36 44 39 22 21 52 40 39.8 days
Cash Conversion Cycle 185 276 640 18775 9647 8902 11699 39505 10947 11083 399 476 259 182 210 289 299 240 273 250 250.1 days
Fixed Asset Turnover snapshot only 3.464
Operating Cycle snapshot only 289.9 days
Cash Velocity snapshot only 1.788
Capital Intensity snapshot only 2.827
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue -15.9% -42.1% -74.1% -99.2% -99.0% -98.6% -97.1% -12.9% -5.6% 0.1% 41.2% 77.2% 116.2% 156.6% 2.9% 1.3% 49.2% 13.5% 14.7% 10.9% 10.86%
Net Income 42.0% -81.4% -1.2% -97.9% -97.5% -91.1% 1.1% -29.6% -1.7% 11.3% 26.5% 69.5% 107.1% 114.0% 3.3% 1.2% 28.8% 35.5% 21.6% 15.8% 15.76%
EPS 43.9% -81.2% -1.2% -97.9% -97.5% -91.1% 1.1% -29.6% -1.5% 12.0% 27.2% 70.9% 111.5% 118.2% 3.4% 1.3% 36.0% 44.5% 27.0% 19.6% 19.64%
FCF -1.0% -1.6% -2.0% -2.7% -37.4% 7.2% 70.4% 45.7% 7.7% -58.8% -2.0% -17.4% -25.0% -29.5% -32.5% -1.4% 44.1% 1.1% 1.4% 78.6% 78.59%
EBITDA -71.2% -67.2% -85.8% -80.8% -53.3% -97.4% -1.2% -97.6% -96.4% 24.5% 31.6% 246.3% 576.7% 11.6% 3.0% 2.7% -45.5% -20.7% -12.0% -23.3% -23.28%
Op. Income -1.1% -1.3% -1.7% -1.0% 89.4% 96.6% 99.7% 31.4% 1.2% 1.6% 445.8% 255.1% 1717.8% 369.4% 90.2% 1.9% 37.5% -1.8% -1.6% -1.5% -1.53%
OCF Growth snapshot only 11.13%
Asset Growth snapshot only 13.42%
Equity Growth snapshot only 10.81%
Debt Growth snapshot only -1.73%
Shares Change snapshot only -3.24%
Dividend Growth snapshot only 12.38%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y -10.1% -20.3% -38.0% -80.1% -80.3% -80.4% -80.3% -80.1% -79.9% -80.0% -31.8% -17.4% 4.1% 29.8% 68.9% 4.4% 4.5% 4.6% 4.7% 4.8% 4.82%
Revenue 5Y — — — -49.3% -56.8% -60.5% -63.1% -63.2% -62.9% -62.9% -21.8% -11.7% -3.2% 3.5% 4.9% 6.9% 7.2% 7.5% 7.4% 7.2% 7.24%
EPS 3Y -27.8% -51.0% — -72.6% -73.2% -73.0% -72.3% -69.6% -67.1% -73.4% -20.8% 2.4% 40.8% 1.3% — 3.9% 4.3% 4.8% 4.4% 4.8% 4.82%
EPS 5Y — — — -29.8% -49.1% -55.4% -58.8% -61.1% -60.8% -58.9% -11.6% 0.8% 16.4% 21.4% 21.5% 35.9% 40.4% 26.5% 22.8% 24.1% 24.09%
Net Income 3Y -28.1% -51.2% — -72.7% -73.3% -73.1% -72.5% -69.7% -67.3% -73.6% -21.9% 1.5% 38.8% 1.3% — 3.8% 4.2% 4.6% 4.2% 4.6% 4.61%
Net Income 5Y — — — -30.5% -49.6% -55.8% -59.2% -61.3% -60.9% -59.0% -12.3% 0.1% 15.1% 20.1% 19.7% 33.5% 37.4% 23.5% 19.9% 21.2% 21.24%
EBITDA 3Y -46.9% -44.0% -54.2% -51.7% -49.6% -79.0% — -84.9% -83.1% -39.6% -6.0% 5.1% 1.1% 1.0% 1.9% 1.8% 1.2% 5.3% — 7.9% 7.86%
EBITDA 5Y — — — 1.3% -21.7% -60.4% — -71.4% -69.8% -34.8% -11.0% -7.4% 21.4% 24.3% 19.5% 25.4% 8.6% 17.1% 24.0% 26.7% 26.72%
Gross Profit 3Y -19.5% -28.6% -45.5% -81.8% -81.9% -81.9% -81.5% -81.0% -80.5% -80.3% -80.3% -35.0% -6.9% 21.7% 78.1% 4.4% 4.5% 4.7% 4.7% 4.8% 4.78%
Gross Profit 5Y — — — -52.0% -59.2% -62.8% -65.2% -65.4% -65.1% -64.8% -64.7% -27.7% -14.8% -6.4% 1.8% 4.8% 6.0% 7.1% 7.2% 7.1% 7.08%
Op. Income 3Y — — — — — — — — -88.1% -81.3% -2.3% 10.2% — — — — — — — — —
Op. Income 5Y — — — — — — — — -81.5% -74.8% -19.6% -20.1% -4.6% -2.5% 0.6% 25.5% 32.0% — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — 20.7% 67.7% — —
OCF 3Y -9.1% -42.0% — 68.3% 1.2% 1.6% 2.0% — — — — — — — — 0.6% 47.5% 57.5% 62.0% — —
OCF 5Y — — — 90.8% 92.0% 92.4% 92.6% — — — — — — — — 37.7% 91.8% 1.1% 1.2% 1.2% 1.18%
Assets 3Y -77.7% -78.3% -78.2% 0.5% -79.8% -80.6% -80.3% -8.1% -81.8% -82.0% -81.7% 3.8% 3.8% 3.9% 3.9% 4.0% 4.2% 3.0% 4.3% 4.5% 4.50%
Assets 5Y — — — 3.1% -61.0% -61.8% -61.6% -3.4% -62.5% -62.9% -61.9% 1.7% 4.2% 3.3% 1.7% 1.6% -1.3% -63.3% -0.2% 1.6% 1.58%
Equity 3Y -77.9% -78.5% -78.4% 4.0% -79.8% -80.5% -80.3% 3.8% -81.5% -81.7% -2.8% 0.1% 3.8% 3.9% 3.9% 1.2% 4.2% 4.3% 4.3% 6.1% 6.10%
Book Value 3Y -77.8% -78.4% -78.3% 4.0% -79.7% -80.4% -80.2% 3.8% -81.4% -81.6% -1.5% 1.0% 3.9% 4.0% 4.1% 3.8% 4.4% 4.5% 4.4% 10.0% 9.97%
Dividend 3Y 1.7% 1.7% 1.7% 1.6% 1.5% 1.4% 1.3% 3.0% 4.7% 6.5% 8.7% 7.9% 8.0% 7.7% 8.2% 7.1% 6.5% 5.6% 4.3% 6.6% 6.58%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.94 0.81 0.68 0.00 0.14 0.48 0.76 0.70 0.81 0.88 0.69 0.40 0.17 0.02 0.00 0.05 0.09 0.13 0.16 0.20 0.197
Earnings Stability 0.09 0.47 0.72 0.07 0.32 0.67 0.78 0.80 0.83 0.87 0.39 0.07 0.04 0.05 0.10 0.31 0.49 0.45 0.51 0.60 0.599
Margin Stability 0.85 0.84 0.83 0.86 0.85 0.84 0.83 0.86 0.86 0.86 0.43 0.69 0.78 0.82 0.44 0.72 0.84 0.89 0.46 0.74 0.739
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.50 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.83 0.50 0.20 0.50 0.50 0.50 0.20 0.88 0.99 0.95 0.50 0.50 0.50 0.50 0.50 0.50 0.88 0.86 0.91 0.94 0.937
Earnings Smoothness 0.65 0.00 — 0.00 0.00 0.00 — 0.65 0.98 0.89 0.00 0.00 0.00 0.00 0.00 0.26 0.75 0.70 0.80 0.85 0.854
ROE Trend 1.83 0.48 -0.66 -0.80 -0.87 -0.20 0.37 -0.01 -0.89 -0.21 0.30 0.02 -0.02 -0.02 0.02 0.04 0.01 0.01 0.03 0.02 0.019
Gross Margin Trend -0.11 -0.11 -0.11 -0.04 -0.01 0.01 0.03 0.00 0.01 0.01 -0.45 -0.25 -0.15 -0.11 0.25 0.14 0.09 0.07 0.23 0.11 0.105
FCF Margin Trend -0.00 -0.00 -0.01 -0.17 -0.14 -0.11 -0.07 -0.02 -0.07 -0.12 0.03 0.11 0.11 0.11 -0.01 0.04 0.07 0.10 0.04 0.02 0.020
Sustainable Growth Rate 1.1% -1.4% — -1.1% -1.4% -1.5% -1.5% -1.3% -1.9% -2.1% -0.4% 1.1% 5.6% 6.5% 3.9% 3.8% 4.0% 5.0% 4.9% 4.4% 4.44%
Internal Growth Rate 0.9% — — — — — — — — — — 1.7% 5.0% 5.8% 6.8% 3.4% 3.6% 8.9% 4.3% 3.9% 3.90%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 0.01 0.02 0.02 3.29 8.36 13.64 15.43 -6.64 -28.96 -49.57 -2.45 -0.98 -0.44 -0.27 -0.14 0.03 0.20 0.31 0.46 0.33 0.326
FCF/OCF -0.04 -3.94 5.05 -0.26 -0.10 -0.05 -0.02 0.10 0.03 0.02 0.02 0.18 0.43 0.91 2.09 -6.07 -0.42 0.05 0.23 -0.11 -0.107
FCF/Net Income snapshot only -0.035
OCF/EBITDA snapshot only 0.291
CapEx/Revenue 0.1% 0.2% 0.5% 14.3% 13.0% 11.4% 9.3% 9.8% 9.9% 10.2% 0.3% 1.3% 1.6% 1.7% 2.2% 3.0% 3.8% 4.6% 5.3% 5.1% 5.11%
CapEx/Depreciation snapshot only 1.056
Accruals Ratio 0.03 0.01 -0.01 -0.12 -0.33 -0.55 -0.75 0.33 1.62 2.98 5.57 0.08 0.11 0.10 0.11 0.05 0.04 0.08 0.03 0.04 0.036
Sloan Accruals snapshot only -0.005
Cash Flow Adequacy snapshot only 0.498
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 5.54%
Dividend/Share $52.66 $53.16 $53.67 $54.00 $54.33 $54.66 $54.99 $58.24 $61.61 $65.16 $69.76 $72.51 $77.56 $80.88 $86.01 $87.41 $89.79 $91.22 $91.70 $98.24 $205.00
Payout Ratio 67.6% 2.6% — 22.4% 27.7% 30.1% 25.5% 34.3% 31.9% 32.0% 1.1% 59.4% 35.7% 33.3% 31.9% 31.3% 30.4% 26.0% 26.8% 29.4% 29.38%
FCF Payout Ratio — — — — — — — — — — — — — — — — — 15.7% 2.5% — —
Total Payout Ratio 85.7% 3.6% — 31.2% 34.9% 33.9% 25.5% 34.3% 31.9% 32.0% 1.1% 86.6% 66.9% 75.3% 83.4% 80.0% 76.0% 63.6% 64.1% 67.5% 67.53%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.67 0.51 1.08 0.78 0.76 0.78 0.76 0.77 0.77 0.77 0.74 0.79 0.77 0.76 0.78 0.77 0.78 0.81 0.80 0.82 0.816
Interest Burden (EBT/EBIT) 0.56 0.20 -0.13 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.23 0.64 0.67 0.93 1.07 1.00 2.77 1.82 1.53 1.57 1.571
EBIT Margin 0.18 0.24 0.44 28.96 26.62 26.61 33.40 27.57 31.14 32.62 0.74 0.28 0.31 0.19 0.17 0.18 0.06 0.11 0.12 0.11 0.110
Asset Turnover 0.40 0.28 0.13 0.26 0.26 0.27 0.26 0.27 0.31 0.33 12.59 0.30 0.46 0.62 0.67 0.35 0.36 0.70 0.38 0.38 0.376
Equity Multiplier 1.22 1.22 1.23 0.01 1.19 1.20 1.19 0.01 1.16 1.16 0.02 0.63 1.17 1.19 0.62 1.18 1.17 0.61 1.19 1.18 1.182
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $77.91 $20.38 $-23.72 $2.41 $1.96 $1.82 $2.15 $1.70 $1.93 $2.04 $60.68 $121.98 $217.26 $242.76 $269.53 $279.43 $295.38 $350.86 $342.22 $334.31 $334.31
Book Value/Share $42.04 $40.23 $37.66 $4366.92 $32.25 $29.97 $32.37 $4204.63 $29.52 $29.31 $4373.75 $4861.62 $4972.54 $4969.09 $4857.71 $4882.68 $4943.33 $5099.27 $5224.85 $5591.78 $5559.43
Tangible Book/Share $7.09 $5.71 $2.77 $4332.89 $-5.37 $-4.82 $-1.30 $4171.95 $-2.64 $-5.22 $4330.69 $4817.61 $4928.49 $4926.95 $4814.75 $4838.43 $4896.30 $5098.94 $5173.63 $5543.94 $5543.94
Revenue/Share $1152.16 $803.46 $375.06 $12.38 $11.73 $11.14 $10.91 $10.78 $11.10 $11.23 $472.92 $858.47 $1354.67 $1833.90 $1927.10 $2063.54 $2133.03 $2220.20 $2307.61 $2364.33 $2378.75
FCF/Share $-0.04 $-1.28 $-2.52 $-2.08 $-1.63 $-1.19 $-0.75 $-1.13 $-1.51 $-1.90 $-2.33 $-21.12 $-40.89 $-60.14 $-81.12 $-52.79 $-24.10 $5.81 $35.97 $-11.68 $0.00
OCF/Share $1.15 $0.33 $-0.50 $7.94 $16.37 $24.81 $33.24 $-11.28 $-55.91 $-100.97 $-148.63 $-119.94 $-94.51 $-66.23 $-38.76 $8.70 $57.82 $107.87 $157.31 $109.07 $0.00
Cash/Share $8.90 $9.57 $7.91 $1152.58 $7.86 $7.76 $7.80 $1075.54 $7.18 $6.94 $961.43 $1014.91 $1038.19 $1130.22 $1027.46 $1136.64 $1163.80 $10.06 $1128.33 $1322.32 $1277.48
EBITDA/Share $42.25 $46.46 $17.08 $19.78 $19.74 $1.22 $-3.26 $0.48 $0.71 $31.39 $102.30 $121.89 $424.61 $410.08 $426.88 $472.98 $244.37 $346.85 $392.27 $375.03 $375.03
Debt/Share $0.46 $0.46 $0.44 $35.56 $0.35 $0.34 $0.37 $32.31 $0.31 $0.29 $30.93 $29.61 $30.31 $28.50 $29.58 $29.90 $30.55 $0.29 $41.80 $30.37 $30.37
Net Debt/Share $-8.44 $-9.11 $-7.47 $-1117.01 $-7.51 $-7.42 $-7.43 $-1043.23 $-6.87 $-6.65 $-930.50 $-985.30 $-1007.87 $-1101.72 $-997.88 $-1106.74 $-1133.25 $-9.77 $-1086.54 $-1291.95 $-1291.95
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 5 4 3 6 6 6 8 3 4 7 5 4 7 6 4 6 5 5 5 6 6
Beneish M-Score 66.83 61.78 67.09 116.92 -4.42 -5.64 -6.36 -0.74 5.54 11.90 171.36 128.27 137.36 156.98 -37.13 -2.42 -2.37 -38.50 -2.20 -2.13 -2.133
Ohlson O-Score snapshot only -11.904
ROIC (Greenblatt) snapshot only 8.84%
Net-Net WC snapshot only $1735.27
EVA snapshot only $-20328356004.04
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only A+
Credit Score 79.60 79.60 76.00 76.30 79.60 79.60 79.60 67.00 76.00 76.00 76.00 76.00 76.00 76.00 76.00 78.40 79.60 82.75 82.75 79.60 79.600
Credit Grade snapshot only 5
Credit Trend snapshot only 1.200
Implied Spread (bps) snapshot only 125.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms